During the past decade, Mercyhealth Hospital and Cancer Center - Janesville conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 26 clinical trials were completed, i.e. on average, 118.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 13 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercyhealth Hospital and Cancer Center - Janesville" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercyhealth Hospital and Cancer Center - Janesville" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Mercyhealth Hospital and Cancer Center - Janesville" are "Recurrent Breast Carcinoma" (7 trials), "Breast Cancer" (6 trials), "Stage IV Breast Cancer AJCC v6 and v7" (6 trials), "Breast Adenocarcinoma" (4 trials) and "HER2/Neu Negative" (4 trials). Many other conditions were trialed in "Mercyhealth Hospital and Cancer Center - Janesville" in a lesser frequency.

Most popular intervention types in "Mercyhealth Hospital and Cancer Center - Janesville" are "Drug" (42 trials), "Other" (35 trials), "Biological" (22 trials), "Procedure" (10 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (16 trials), "Bevacizumab" (9 trials), "Questionnaire Administration" (8 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.

The vast majority of trials in "Mercyhealth Hospital and Cancer Center - Janesville" are 33 trials for "All" genders and 16 trials for "Female" genders.

Currently, there are NaN active trials in "Mercyhealth Hospital and Cancer Center - Janesville". undefined are not yet recruiting, 9 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Mercyhealth Hospital and Cancer Center - Janesville, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mercyhealth Hospital and Cancer Center - Janesville, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".